Keith Valentine - 09 Jun 2023 Form 4 Insider Report for SI-BONE, Inc. (SIBN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Jun 2023, 16:31:02 UTC
Prior SEC filing
02 Mar 2023
Next SEC filing
31 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael A. Pisetsky, Attorney-in-Fact for Keith C. Valentine

Key filing fact

Keith Valentine filed Form 4 for SI-BONE, Inc. (SIBN) on 13 Jun 2023.

Key facts

  • This page summarizes Keith Valentine's Form 4 filing for SI-BONE, Inc. (SIBN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Jun 2023, 16:31.

Change

  • Previous filing in this sequence was filed on 02 Mar 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SIBN transaction

Common Stock

Award

Transaction value
$0
Shares
+4,866
Change %
+9.3%
Price
$0.000000
Shares after
57,209
Date
09 Jun 2023
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date.

Footnote F2

Includes 4,866 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .